WealthPlan Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.82M Sell
16,530
-6,723
-29% -$2.4M 0.32% 77
2025
Q4
$7.61M Sell
23,253
-14,878
-39% -$4.72M 0.49% 60
2025
Q3
$10.8M Sell
38,131
-2,176
-5% -$631K 0.71% 48
2025
Q2
$11.3M Buy
40,307
+4,479
+13% +$1.27M 0.82% 35
2025
Q1
$11.2M Buy
35,828
+2,170
+6% +$641K 1.1% 24
2024
Q4
$8.77M Sell
33,658
-5,297
-14% -$1.57M 0.87% 38
2024
Q3
$12.6M Buy
38,955
+5,661
+17% +$1.85M 1.27% 20
2024
Q2
$10.4M Buy
33,294
+28,896
+657% +$8.49M 1.57% 14
2024
Q1
$1.25M Buy
4,398
+1
+0% +$293 0.19% 86
2023
Q4
$1.27M Hold
4,397
0.2% 88
2023
Q3
$1.18M Buy
4,397
+126
+3% +$31.4K 0.21% 81
2023
Q2
$948K Sell
4,271
-76
-2% -$17.6K 0.28% 76
2023
Q1
$1.05M Sell
4,347
-1,215
-22% -$298K 0.18% 84
2022
Q4
$1.36M Sell
5,562
-534
-9% -$143K 0.09% 155
2022
Q3
$1.74M Buy
+6,096
New +$1.48M 0.13% 122
2022
Q1
$1.29M Buy
+5,549
New +$1.27M 0.09% 148

Other funds holding AMGN

WealthPlan Investment Management's AMGN Position: Q1 2026 in Review

WealthPlan Investment Management reduced its Amgen (AMGN) stake by 29% in Q1 2026, selling an estimated $2.4M and leaving 16,530 shares worth $5.82M. The position accounts for 0.32% of the portfolio, ranked #77.

WealthPlan Investment Management first reported a position in AMGN in Q1 2022 and has held it in 16 quarters since. The position peaked at $12.6M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • WealthPlan Investment Management held 16,530 shares of Amgen worth $5.82M as of Q1 2026.
  • WealthPlan Investment Management sold 6,723 Amgen shares in Q1 2026, an estimated $2.4M.
  • Amgen made up 0.32% of WealthPlan Investment Management's portfolio in Q1 2026, its #77 holding.
  • WealthPlan Investment Management first reported a position in Amgen in Q1 2022 and has held it in 16 quarters since.
  • WealthPlan Investment Management's Amgen position peaked at $12.6M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on WealthPlan Investment Management's 13F filing for Q1 2026, filed 29 Apr 2026.